메뉴 건너뛰기




Volumn 5, Issue 1, 2005, Pages 15-21

FibroTest-FibroSURE™: Towards a universal biomarker of liver fibrosis?

Author keywords

ActiTest ; Activity biomaker; Alcoholic liver disease; Fatty liver; Fibrosis biomaker FibroSURE ; Fibrotest HCV; HBV; Liver biopsy limits

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

EID: 12344252849     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.1.15     Document Type: Review
Times cited : (44)

References (39)
  • 1
    • 0037698889 scopus 로고    scopus 로고
    • Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?
    • Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 37, 972-974 (2003).
    • (2003) Hepatology , vol.37 , pp. 972-974
    • Afdhal, N.H.1
  • 2
    • 0036830347 scopus 로고    scopus 로고
    • The role of liver biopsy in chronic hepatitis C
    • Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 36, S152-S160 (2002).
    • (2002) Hepatology , vol.36
    • Dienstag, J.1
  • 4
    • 0036792679 scopus 로고    scopus 로고
    • Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
    • Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97, 2614-2618 (2002).
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 2614-2618
    • Regev, A.1    Berho, M.2    Jeffers, L.J.3
  • 5
    • 0042671303 scopus 로고    scopus 로고
    • Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease
    • Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 39, 239-244 (2003).
    • (2003) J. Hepatol. , vol.39 , pp. 239-244
    • Colloredo, G.1    Guido, M.2    Sonzogni, A.3    Leandro, G.4
  • 6
    • 0345017740 scopus 로고    scopus 로고
    • Sampling variability of liver fibrosis in chronic hepatitis C
    • Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38, 1449-1457 (2003).
    • (2003) Hepatology , vol.38 , pp. 1449-1457
    • Bedossa, P.1    Dargère, D.2    Paradis, V.3
  • 8
    • 0042766810 scopus 로고    scopus 로고
    • Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon α-2b and ribavirin
    • Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon α-2b and ribavirin. Hepatology 38, 481-492 (2003).
    • (2003) Hepatology , vol.38 , pp. 481-492
    • Poynard, T.1    McHutchison, J.2    Manns, M.3    Myers, R.P.4    Albrecht, J.5
  • 9
    • 3242798959 scopus 로고    scopus 로고
    • Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
    • Poynard T, Munteanu M, Imbert-Bismut F et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin. Chem. 50, 1344-1355 (2004).
    • (2004) Clin. Chem. , vol.50 , pp. 1344-1355
    • Poynard, T.1    Munteanu, M.2    Imbert-Bismut, F.3
  • 10
    • 0036829484 scopus 로고    scopus 로고
    • Role of liver biopsy in management of chronic hepatitis C: A systematic review
    • Gebo KA, Herlong HF, Torbenson MS et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36, S161-S172 (2002).
    • (2002) Hepatology , vol.36
    • Gebo, K.A.1    Herlong, H.F.2    Torbenson, M.S.3
  • 11
    • 0035820265 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study
    • Imbert-Bismut F, Ratziu V, Laurence Pieroni L et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357, 1069-1075 (2001).
    • (2001) Lancet , vol.357 , pp. 1069-1075
    • Imbert-Bismut, F.1    Ratziu, V.2    Laurence Pieroni, L.3
  • 12
    • 0036906034 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: Longitudinal validation in a randomized trial
    • Poynard T, Imbert-Bismut F, Ratziu V et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepatitis 9, 128-133 (2002).
    • (2002) J. Viral Hepatitis , vol.9 , pp. 128-133
    • Poynard, T.1    Imbert-Bismut, F.2    Ratziu, V.3
  • 13
    • 0036734486 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C
    • Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am. J. Gastroenterol. 97, 2419-2425 (2002).
    • (2002) Am. J. Gastroenterol. , vol.97 , pp. 2419-2425
    • Myers, R.P.1    Ratziu, V.2    Imbert-Bismut, F.3    Charlotte, F.4    Poynard, T.5
  • 14
    • 0037471273 scopus 로고    scopus 로고
    • Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients
    • Myers RP, Benhamou Y, Imbert-Bismut F et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients. AIDS 17, 1-5 (2003).
    • (2003) AIDS , vol.17 , pp. 1-5
    • Myers, R.P.1    Benhamou, Y.2    Imbert-Bismut, F.3
  • 15
    • 0037280482 scopus 로고    scopus 로고
    • Biochemical markers of fibrosis in patients with chronic hepatitis C: A comparison with prothrombin time, platelet count and the age-platelet index
    • Myers RP, de Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count and the age-platelet index. Dig. Dis. Sci. 48, 146-153 (2003).
    • (2003) Dig. Dis. Sci. , vol.48 , pp. 146-153
    • Myers, R.P.1    De Torres, M.2    Imbert-Bismut, F.3    Ratziu, V.4    Charlotte, F.5    Poynard, T.6
  • 16
    • 85081151208 scopus 로고    scopus 로고
    • Non-invasive prediction of fibrosis in patients with chronic hepatitis C
    • Thabut D, Simon M, Myers RP et al. Non-invasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 37, 1220-12221 (2003).
    • (2003) Hepatology , vol.37 , pp. 1220-12221
    • Thabut, D.1    Simon, M.2    Myers, R.P.3
  • 17
    • 1542724800 scopus 로고    scopus 로고
    • Fibrotest has higher predictive values than APRI for fibrosis diagnosis in patients with chronic hepatitis C
    • LeCalvez S, Thabut D, Messous D et al. Fibrotest has higher predictive values than APRI for fibrosis diagnosis in patients with chronic hepatitis C. Hepatology 39, 862-863 (2004).
    • (2004) Hepatology , vol.39 , pp. 862-863
    • LeCalvez, S.1    Thabut, D.2    Messous, D.3
  • 18
    • 0042553522 scopus 로고    scopus 로고
    • A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
    • Halfon P, Imbert-Bismut F, Messous D et al. A prospective assessment of the interlaboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp. Hepatol. 1, 3-7 (2002).
    • (2002) Comp. Hepatol. , vol.1 , pp. 3-7
    • Halfon, P.1    Imbert-Bismut, F.2    Messous, D.3
  • 19
    • 0037371363 scopus 로고    scopus 로고
    • Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients
    • Rossi E, Adams L, Prins A et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin. Chem. 49, 450-454 (2003).
    • (2003) Clin. Chem. , vol.49 , pp. 450-454
    • Rossi, E.1    Adams, L.2    Prins, A.3
  • 20
    • 0141480785 scopus 로고    scopus 로고
    • Fibrotest even better than liver biopsy?
    • Electronic letter. Response: (21 March 2003)
    • Poynard T, Imbert-Bismut F, Ratziu V et al. Fibrotest even better than liver biopsy? Clin. Chem. 2003. Electronic letter http://www.clinchem.org/cgi/ eletters/49/3/450. Response: (21 March 2003)
    • (2003) Clin. Chem.
    • Poynard, T.1    Imbert-Bismut, F.2    Ratziu, V.3
  • 21
    • 0141869032 scopus 로고    scopus 로고
    • Cost effectiveness of pegylated interferon α2b and ribavirin combination in chronic hepatitis C
    • Poynard T. Cost effectiveness of pegylated interferon α2b and ribavirin combination in chronic hepatitis C. Gut 52, 1532 (2003).
    • (2003) Gut , vol.52 , pp. 1532
    • Poynard, T.1
  • 22
    • 11144355931 scopus 로고    scopus 로고
    • Intra-laboratory analytical variability of biochemical markers of fibrosis (FibroTest) and activity (Actitest) and reference ranges in healthy blood donors
    • Imbert-Bismut F, Messous D, Thibaut V et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (FibroTest) and activity (Actitest) and reference ranges in healthy blood donors. Clin. Chem. Lab. Med. 42(3) 323-333 (2004).
    • (2004) Clin. Chem. Lab. Med. , vol.42 , Issue.3 , pp. 323-333
    • Imbert-Bismut, F.1    Messous, D.2    Thibaut, V.3
  • 23
    • 13644263674 scopus 로고    scopus 로고
    • Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest)
    • Munteanu M, Messous D, Thabut D et al. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest). Comp. Hepatol. 3, 3 (2004).
    • (2004) Comp. Hepatol. , vol.3 , pp. 3
    • Munteanu, M.1    Messous, D.2    Thabut, D.3
  • 25
    • 12344267742 scopus 로고    scopus 로고
    • Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-FibtoSURE) and necrosis (ActiTest) in patients with chronic hepatitis C
    • Poynard T, Imbert-Bismut F, Munteanu M et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-FibtoSURE) and necrosis (ActiTest) in patients with chronic hepatitis C Comp. Hepatol. Comp. Hepatol. 3, 8 (2004).
    • (2004) Comp. Hepatol. Comp. Hepatol. , vol.3 , pp. 8
    • Poynard, T.1    Imbert-Bismut, F.2    Munteanu, M.3
  • 27
    • 10844238015 scopus 로고    scopus 로고
    • Independent prospective multicenter validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C
    • Halfon P, Bourliere M, Deydier R et al. Independent prospective multicenter validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C. Hepatology 38, 188A (2003).
    • (2003) Hepatology , vol.38
    • Halfon, P.1    Bourliere, M.2    Deydier, R.3
  • 28
    • 12344269845 scopus 로고    scopus 로고
    • Comparision of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis
    • Borroni G, Cazzaniga M, Ceriani R et al. Comparision of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis. J. Hepatol. 40, 137 (2004).
    • (2004) J. Hepatol. , vol.40 , pp. 137
    • Borroni, G.1    Cazzaniga, M.2    Ceriani, R.3
  • 29
    • 4544274791 scopus 로고    scopus 로고
    • FIBROSpect II: A potential noninvasive test to assess hepatic fibrosis
    • Poordad FF. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis. Expert Rev. Mol. Diagn. 4, 593-597 (2004).
    • (2004) Expert Rev. Mol. Diagn. , vol.4 , pp. 593-597
    • Poordad, F.F.1
  • 30
    • 0003179169 scopus 로고
    • Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C
    • The METAVIR co-operative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 20(1), 15-20 (1994).
    • (1994) Hepatology , vol.20 , Issue.1 , pp. 15-20
  • 31
    • 0029778988 scopus 로고    scopus 로고
    • An algorithm for the grading of activity in chronic hepatitis C
    • The METAVIR Co-operative Study Group
    • Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Co-operative Study Group. Hepatology 24, 289-293 (1996).
    • (1996) Hepatology , vol.24 , pp. 289-293
    • Bedossa, P.1    Poynard, T.2
  • 32
    • 10744221863 scopus 로고    scopus 로고
    • Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
    • Myers RP, Tainturier MH, Ratziu V et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J. Hepatol. 39, 222-230 (2003).
    • (2003) J. Hepatol. , vol.39 , pp. 222-230
    • Myers, R.P.1    Tainturier, M.H.2    Ratziu, V.3
  • 33
    • 12344335496 scopus 로고    scopus 로고
    • The diagnostic value of biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease
    • In Press
    • Naveau S, Raynard B, Ratziu V et al. The diagnostic value of biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin. Gastroenterol. Hepatol. (2005) (In Press).
    • (2005) Clin. Gastroenterol. Hepatol.
    • Naveau, S.1    Raynard, B.2    Ratziu, V.3
  • 34
    • 12344337297 scopus 로고    scopus 로고
    • Diagnostic value of biochemical markers (FibroTest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    • Ratziu V, Lecalvez S, Imbert-Bismut F et al. Diagnostic value of biochemical markers (FibroTest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Hepatology 38, 510A (2003).
    • (2003) Hepatology , vol.38
    • Ratziu, V.1    Lecalvez, S.2    Imbert-Bismut, F.3
  • 35
    • 3242768719 scopus 로고    scopus 로고
    • Diagnostic value of fibrosis biochemical markers (FibroTest) for the prediction of portal hypertension in liver disease
    • Thabut D, Imbert-Bismut F, Cazals-Athem D et al. Diagnostic value of fibrosis biochemical markers (FibroTest) for the prediction of portal hypertension in liver disease. Hepatology 38, 282A (2003).
    • (2003) Hepatology , vol.38
    • Thabut, D.1    Imbert-Bismut, F.2    Cazals-Athem, D.3
  • 36
    • 3242800803 scopus 로고    scopus 로고
    • Diagnostic value of fibrosis biochemical markers (FibroTest) for the screening of oesophageal varices in patients with chronic liver disease
    • Thabut D, Trabut JB, Le Calvez S et al. Diagnostic value of fibrosis biochemical markers (FibroTest) for the screening of oesophageal varices in patients with chronic liver disease. Hepatology 38, 284A (2003).
    • (2003) Hepatology , vol.38
    • Thabut, D.1    Trabut, J.B.2    Le Calvez, S.3
  • 38
    • 12344309018 scopus 로고    scopus 로고
    • Prospective comparison of transient elastography, fibrotest, apri and liver biopsy for the assessment of fibrosis in chronic hepatitis C
    • In Press
    • Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, fibrotest, apri and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology (2005) (In Press).
    • (2005) Gastroenterology
    • Castera, L.1    Vergniol, J.2    Foucher, J.3
  • 39
    • 4544236421 scopus 로고    scopus 로고
    • Noninvasive diagnosis of fibrosis in chronic liver disease
    • Lichtinghagen R, Bahr MJ. Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev. Mol. Diagn. 4, 715-726 (2004).
    • (2004) Expert Rev. Mol. Diagn. , vol.4 , pp. 715-726
    • Lichtinghagen, R.1    Bahr, M.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.